Myotonic Dystrophy: Etiology, Clinical Features, and Diagnosis
UptoDate 2022 Jan, Darras, B.T., 2022
Neurological Management of Von Hippel-Lindau Disease
Neurologist 21:73-78, Hodgson, T.S.,et al, 2016
Treatment of Brain Metastases
J Clin Oncol 33:3475-3484, Lin, X. & DeAngelis, L.M., 2015
Detection of Unknown Primary Tumor in a Patient with Cerebellar Metastasis Using FDG PET-CT: Case Report
No Shinkei Geka 34:1027-1032, Ishiguro,T.,et al, 2006
Whole-Body MRI and PET-CT in the Management of Cancer Patients
Eur Radiol 16:1216-1225, Schmidt,G.P.,et al, 2006
Diagnostic Evaluation of Patients with a Brain Mass as the Presenting Manifestation of Cancer
Neurol 65:908-911, Mavrakis,A.N.,et al, 2005
Unknown Primary Tumors: Detection with Dual-Modality PET/CT--Initial Experience
Radiology 234:227-234, Gutzeit,A.,et al, 2005
Brain Metastases from an Unknown Primary Tumour:Which Diagnostic Procedures are Indicated
JNNP 61:321-323, van de Pol,M.,et al, 1996
Central Nervous System Lesions in von Hippel-Lindau Syndrome
JNNP 55:898-901, Neumann,H.P.H.,et al, 1992
Neurologic Complications of Systemic Cancer
In Neurologic Clinics 3:729-750, Patchell,R.A.&Posner,J.B., 1985